Vivos Inc. is a late stage development company. It engaged primarily in the development of brachytherapy devices for therapeutic applications. Vivos Inc., formerly known as Advanced Medical Isotope Corporation, is based in Richland, Washington.
| Revenue (Most Recent Fiscal Year) | $0.07M |
| Net Income (Most Recent Fiscal Year) | $-3.07M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 388.58 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -4379.49% |
| Net Margin (Trailing 12 Months) | -4380.77% |
| Return on Equity (Trailing 12 Months) | -- |
| Return on Assets (Trailing 12 Months) | -138.20% |
| Current Ratio (Most Recent Fiscal Quarter) | 15.13 |
| Quick Ratio (Most Recent Fiscal Quarter) | 14.80 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | -- |
| Inventory Turnover (Trailing 12 Months) | 2.27 |
| Book Value per Share (Most Recent Fiscal Quarter) | $-0.02 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.01 |
| Exchange | -- |
| Sector | -- |
| Industry | -- |
| Common Shares Outstanding | 493.64M |
| Free Float | 402.32M |
| Market Capitalization | $30.31M |
| Average Volume (Last 20 Days) | 1.01M |
| Beta (Past 60 Months) | -0.76 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 18.50% |
| Percentage Held By Institutions (Latest 13F Reports) | 0.00% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |